Back

Prognostic relevance of exercise pulmonary hypertension for new-onset atrial fibrillation in primary mitral regurgitation

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Echocardiography in Valvular Heart Disease: New Insights Stress Echocardiography ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Kanako Teramoto

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

8 More presentations in this session

Presentation thumbnail
One-year echocardiographic outcomes of transcatheter aortic valve implantation with or without predilatation of the aortic valve: Insights from the multicenter, randomized DIRECT trial.
Doctor M. Karmpalioti (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognosis and clinical outcomes after TAVI, regarding the extravalvular cardiac damage defined by echocardiography prior the procedural.
Doctor J. Borrego Rodriguez (Bilbao, ES)
Abstract Slides Video
Presentation thumbnail
Flow rate and stroke volume index as predictors of mortality in patients undergoing transcatheter aortic valve implantation
Doctor S. Abdelrazek (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
The five-beat averaged method of assessing aortic stenosis in atrial fibrillation significantly underestimates stenosis severity compared to sinus rhythm.
Doctor S. Tomlinson (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Ischaemic mitral regurgitation: incidence, clinical and angiographic characteristics of 1000 patients with type 1 myocardial infarction undergoing percutaneous coronary intervention
Doctor H. Sharma (Birmingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Echocardiography in Valvular Heart Disease: New Insights

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
The do’s and don’ts from the EACVI clinical consensus statement on stress echocardiography
thumbnail
Congress Presentation
Stress echocardiography best defines risk
thumbnail
Congress Presentation
Valvular heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources